Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Ann Surg. 2021 Jun 1;273(6):e206–e213. doi: 10.1097/SLA.0000000000003455

FIGURE 4.

FIGURE 4.

Esophageal Adenocarcinoma at 40 weeks in the itraconazole versus control groups. A, Gross section of distal esophageal adenocarcinoma with hematoxylin and eosin staining showing a well-differentiated adenocarcinoma. B, Percentage of the adenocarcinoma positive rats in the treatment arm versus control arm at week 40 after surgery. 8.3% (2/24) versus 32.3% (10/31), P = 0.033.